Ratings MetLife, Inc.

Equities

MET

US59156R1086

Market Closed - Nyse 04:00:02 2024-04-26 pm EDT 5-day change 1st Jan Change
70.42 USD -2.06% Intraday chart for MetLife, Inc. -0.97% +6.49%

Summary

  • The company presents an interesting fundamental situation from a short-term investment perspective.
  • The company has a good ESG score relative to its sector, according to Refinitiv.

Strengths

  • The earnings growth currently anticipated by analysts for the coming years is particularly strong.
  • Its low valuation, with P/E ratio at 8.71 and 7.73 for the ongoing fiscal year and 2025 respectively, makes the stock pretty attractive with regard to earnings multiples.
  • The company has a low valuation given the cash flows generated by its activity.
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
  • There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.

Weaknesses

  • According to forecast, a sluggish sales growth is expected for the next fiscal years.
  • As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
  • One of the major weak points of the company is its financial situation.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Life & Health Insurance

1st Jan change Capi. Investor Rating ESG Refinitiv
+6.49% 51.99B
B+
+1.35% 48.18B
B
+9.53% 41.99B
B+
+6.55% 39.96B
B+
+19.34% 37.85B
B
+2.84% 29.82B
B
-7.77% 27.37B
B-
-18.42% 24.45B
A-
+6.89% 21.84B
A
+20.69% 21.14B
B
Investor Rating
Trading Rating
ESG Refinitiv

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Environment

Emissions
Innovation
Use of resources

Social

Social commitment
Human Rights
Product liability
Human Resources

Governance

CSR Strategy
Management
Shareholders

Controversy

Controversy

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. MET Stock
  4. Ratings MetLife, Inc.